FDA extends Blenrep combo review to October to assess more data from Phase 3 trials in relapsed or refractory multiple myeloma.

The EU approves belantamab mafodotin combinations, enhancing treatment options for relapsed multiple myeloma patients with ...

Q2 2025 Earnings Call Transcript July 22, 2025 Operator: Good day, and welcome to the Alexandria Real Estate Equities Second ...

Intravenous fosfomycin (IVFOF) is becoming increasingly utilized for the treatment of severe infections; however, its broader adoption is often limited by ...

Anyone who has submitted a medical device for pre-market review knows the financial investment it takes to for FDA to conduct ...

Pharmacists say insurance reimbursements fail to cover their costs. They say a new law isn't enough to reverse the trend.